| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CONICET, Center of Nuclear Medicine, Hospital de Clínicas, University of Buenos Aires 1453 Buenos Aires, Argentina
Address requests for reprints to: Dr. A. A. Zaninovich, Hospital de Clinicas, C.C. 29-Suc. 53, 1453 Buenos Aires, Argentina.
The peripheral metabolism of T3 has been studied in 10 hypothyroid patients receiving daily oral replacement doses of 200 µg T4 or 60 µg T3, in divided doses, before and during treatment with 400 mg amiodarone (AMD) daily for 3 weeks. Each patient received 1 µCi/kg BW [125I]T3, iv. Blood samples were drawn at 10, 20, 30, and 60 min and 2, 4, 6, 8, 12, 24, 36, 48, 60, and 72 h, followed by trichloroacetic acid precipitation and ethanol extraction of the serum samples. The parameters of T3 kinetics were obtained from the area under the disappearance curve of [125I]T3 from serum using a noncompartmental analysis. In five T4-treated patients, AMD induced a significant increase in serum T4 (P < 0.02), serum free T4 (P < 0.01), and serum TSH (P < 0.02) and a marked decrease in serum T3 (P < 0.005). Fractional turnover and MCRs were not affected by the drug. However, the extrathyroidal pool of T3 (P < 0.02) and its degradation rate (P < 0.001) were both significantly diminished. In the five T3-treated patients, AMD did not induce alterations in the parameters of T3 kinetics or in serum T3 and TSH concentrations. The data clearly establish that AMD does not affect the distribution and fractional removal of T3 from the plasma pool, but only its generation from T4 in extrathyroidal tissues. This conclusion does not rule out the possibility that the drug may interfere with a number of intracellular events dependent on T3 action which may be independent of T3 deiodination.
* This work was supported by Grant PID-005 from the National Research Council (CONICET) and the Atomic Energy Commission, Argentina.
Received August 17, 1989.
This article has been cited by other articles:
![]() |
E. Martino, L. Bartalena, F. Bogazzi, and L. E. Braverman The Effects of Amiodarone on the Thyroid Endocr. Rev., April 1, 2001; 22(2): 240 - 254. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |